Inhibition of vascular endothelial growth factor with a sequence-specific hypoxia response element antagonist
Open accessThe DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index.
Abstract
Vascular endothelial growth factor (VEGF) and its receptors have been implicated as key factors in tumor angiogenesis that are up-regulated by hypoxia. We evaluated the effects of DNA-binding small molecules on hypoxia-inducible transcription of VEGF . A synthetic pyrrole-imidazole polyamide designed to bind the hypoxia response element (HRE) was found to disrupt hypoxia-inducible factor (HIF) binding to HRE. In cultured HeLa cells, this resulted in a reduction of VEGF mRNA and secreted protein levels. The observed effects were polyamide-specific and dose-dependent. Analysis of genome-wide effects of the HRE-specific polyamide revealed that a number of hypoxia-inducible genes were down-regulated. Pathway-based regulation of hypoxia-inducible gene expression with DNA-binding small molecules may represent a new approach for targeting angiogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Interestingly, a synthetic pyrroleimidazole polyamide that inhibits in a sequence-specific fashion HIF binding to the HRE of the VEGF promoter (44) caused 264 and 73 genes to be down-regulated and up-regulated by 2-fold, respectively, at a concentration of 1 Amol/L.”
From Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activity. (2005) · cites this paper as [44]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
Leung, D. W., Cachianes, G., Kuang, W.-J., Goeddel, D. V., & Ferrara, N. (1989) · Science · doi:10.1126/science.2479986 · Cited by 4,986
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
Forsythe, J. A., Jiang, B.-H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., & Semenza, G. L. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4604 · Cited by 3,981
Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., & Ferrara, N. (1993) · Nature · doi:10.1038/362841a0 · Cited by 3,605
Plate, K. H., Breier, G., Weich, H. A., & Risau, W. (1992) · Nature · doi:10.1038/359845a0 · Cited by 2,275
Tischer, E., Mitchell, R., Hartman, T., Silva, M., Gospodarowicz, D., Fiddes, J. C., & Abraham, J. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99049-6 · Cited by 1,476
Transcription factors as targets for cancer therapy
Darnell, J. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc906 · Cited by 1,194
Molecular basis of the VHL hereditary cancer syndrome
Kaelin, W. G. (2002) · Nature Reviews Cancer · doi:10.1038/nrc885 · Cited by 865
Self-citation
Research works printed but not linked: 5
- O'Rourke, J. F., Dachs, G. U., Gleadle, J. M., Maxwell, P. H., Pugh, C. W., Stratford, I. J., Wood, S. M. & Ratcliffe, P. J. (1997) Oncol. Res. 9, 327–332.9406238
- Grimshaw, M. J., Naylor, S. & Balkwill, F. R. (2002) Mol. Cancer Ther. 1, 1273-1281.
- Kang, S. M., Maeda, K., Chung, Y. S., Onoda, N., Ogawa, Y., Takatsuka, S., Ogawa, M., Sawada, T., Nakata, B., Nishiguchi, Y., et al. (1997) Oncol. Rep. 4, 381-384.
- Lin, P. N., Sankar, S., Shan, S. Q., Dewhirst, M. W., Polverini, P. J., Quinn, T. Q. & Peters, K. G. (1998) Cell Growth Differ. 9, 49-58.
- Reich, S., Fosnot, J., Kuroki, A., Tang, W. X., Yang, X. Y., Maguire, A., Bennett, J. & Tolentino, M. (2003) Mol. Vis. 9, 210-216.
Cited by
Items 101–200 of 221
Targeting a DNA Binding Motif of the EVI1 Protein by a Pyrrole–Imidazole Polyamide
Zhang, Y., Sicot, G., Cui, X., Vogel, M., Wuertzer, C. A., Lezon-Geyda, K., Wheeler, J., Harki, D. A., Muzikar, K. A., Stolper, D. A., et al. (2011) · Biochemistry · doi:10.1021/bi200962u · Cited by 35
Self-citationQuantitating the concentration of Py-Im polyamide–fluorescein conjugates in live cells
Hsu, C. F., & Dervan, P. B. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.05.063 · Cited by 35
Self-citationHypoxia in Cancer and Fibrosis: Part of the Problem and Part of the Solution
Romero, Y., & Aquino‐Gálvez, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158335 · Cited by 41
“These heterodimers within the nucleus recognize the sequence TACGTG, called the hypoxia response element (HRE), located in the promoter regions of genes involved in hematopoiesis, angiogenesis, iron transport, glucose consumption, MEC synthesis, cell growth and differentiation, among other functions [6].”
BackgroundAlkylation of template strand of coding region causes effective gene silencing
Shinohara, K. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl005 · Cited by 35
“Therefore, many genes, including vascular endothelial growth factor (11) and human estrogen-related receptor 2 (12), are silenced by competitive binding of Py– Im hairpin polyamides to their regulatory sequences (13,14).”
BackgroundAnimal Toxicity of Hairpin Pyrrole-Imidazole Polyamides Varies with the Turn Unit
Yang, F., Nickols, N. G., Li, B. C., Szablowski, J. O., Hamilton, S. R., Meier, J. L., Wang, C.-M., & Dervan, P. B. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401100s · Cited by 36
Self-citationAdvancing Small‐Molecule‐Based Chemical Biology with Next‐Generation Sequencing Technologies
Chandran, A., Kizaki, S., Bando, T., Pandian, G. N., & Sugiyama, H. (2014) · ChemBioChem · doi:10.1002/cbic.201402556 · Cited by 39
Solution-Phase Synthesis of Pyrrole−Imidazole Polyamides
Chenoweth, D. M., Harki, D. A., & Dervan, P. B. (2009) · Journal of the American Chemical Society · doi:10.1021/ja901307m · Cited by 32
Self-citationYap, J. L., Chauhan, J., Jung, K., Chen, L., Prochownik, E. V., & Fletcher, S. (2012) · MedChemComm · doi:10.1039/c2md00289b · Cited by 36
CUL2 Is Required for the Activity of Hypoxia-inducible Factor and Vasculogenesis
Maeda, Y., Suzuki, T., Pan, X., Chen, G., Pan, S., Bartman, T., & Whitsett, J. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710223200 · Cited by 32
Gong, F., Chen, M., Zhang, Y., Li, C., Zhou, C., Hong, P., Sun, S., & Qian, Z. (2019) · Marine Drugs · doi:10.3390/md17040244 · Cited by 31
“Hypoxic induced factor (HIF-1α) overexpression in tumor cells promotes the expression of vascular endothelial growth factor (VEGF), related to VM formation [13,14].”
BackgroundProtein–protein interactions in transcription: A fertile ground for helix mimetics
Guarracino, D. A., Bullock, B. N., & Arora, P. S. (2010) · Biopolymers · doi:10.1002/bip.21546 · Cited by 38
Microwave Assisted Synthesis of Py-Im Polyamides
Puckett, J. W., Green, J. T., & Dervan, P. B. (2012) · Organic Letters · doi:10.1021/ol3010003 · Cited by 31
Self-citationPharmacokinetics of Py-Im Polyamides Depend on Architecture: Cyclic versus Linear
Raskatov, J. A., Hargrove, A. E., So, A. Y., & Dervan, P. B. (2012) · Journal of the American Chemical Society · doi:10.1021/ja302588v · Cited by 30
Self-citationTumor Repression of VCaP Xenografts by a Pyrrole-Imidazole Polyamide
Hargrove, A. E., Martinez, T. F., Hare, A. A., Kurmis, A. A., Phillips, J. W., Sud, S., Pienta, K. J., & Dervan, P. B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143161 · Cited by 32
Self-citationTumor Hypoxia As an Enhancer of Inflammation-Mediated Metastasis: Emerging Therapeutic Strategies
DiGiacomo, J. W., & Gilkes, D. M. (2018) · Targeted Oncology · doi:10.1007/s11523-018-0555-4 · Cited by 31
Small-molecule regulators that mimic transcription factors
Rodríguez‐Martínez, J. A., Peterson‐Kaufman, K. J., & Ansari, A. Z. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2010.08.010 · Cited by 29
Advances and Prospects of Vasculogenic Mimicry in Glioma: A Potential New Therapeutic Target?
Cai, H., Liu, W., Liu, X., Li, Z., Feng, T., Xue, Y., & Liu, Y. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s247855 · Cited by 28
Viger, A., & Dervan, P. B. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.08.028 · Cited by 28
Self-citationKageyama, Y., Sugiyama, H., Ayame, H., Iwai, A., Fujii, Y., Huang, E. L., Kizaka‐Kondoh, S., Hiraoka, M., & Kihara, K. (2006) · Acta Oncologica · doi:10.1080/02841860500486648 · Cited by 30
“Recently, a hairpin polyamide that recognizes TACG within the HRE has been reported to inhibit VEGF transcription [16].”
BackgroundMinoshima, M., Bando, T., Shinohara, K., Kashiwazaki, G., Nishijima, S., & Sugiyama, H. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.12.033 · Cited by 26
Huang, R., CHANG, C., & Mold, D. E. (2006) · Seminars in Oncology · doi:10.1053/j.seminoncol.2006.04.010 · Cited by 26
Alvarez, D., Chou, C. J., Latella, L., Zeitlin, S. G., Ku, S., Puri, P., Dervan, P. B., & Gottesfeld, J. M. (2006) · Cell Cycle · doi:10.4161/cc.5.14.2913 · Cited by 28
Self-citationSequence-Specificity and Energy Landscapes of DNA-Binding Molecules
Tietjen, J. R., Donato, L. J., Bhimisaria, D., & Ansari, A. Z. (2011) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-385075-1.00001-9 · Cited by 26
VEGF expression is regulated by HIF‐1α and ARNT in 3D KYSE‐70, esophageal cancer cell spheroids
Terashima, J., Sampei, S., Iidzuka, M., Ohsakama, A., Tachikawa, C., Satoh, J., Kudo, K., Habano, W., & Ozawa, S. (2016) · Cell Biology International · doi:10.1002/cbin.10656 · Cited by 29
“…ARNT, aryl hydrocarbon receptor nuclear translocator; 3D, three dimension; HIF-1a, hypoxia-inducible factor-1 alpha; VEGF, vascular endothelial growth factor 1187Cell Biol Int 40 (2016) 1187–1194 © 2016 International Federation for Cell Biology in 2Dmonolayer HeLa cells (Olenyuk et al., 2004).”
BackgroundSynthetic genome readers target clustered binding sites across diverse chromatin states
Erwin, G. S., Grieshop, M. P., Bhimsaria, D., Do, T. J., Rodríguez‐Martínez, J. A., Mehta, C., Khanna, K., Swanson, S. A., Stewart, R. M., Thomson, J. A., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1604847113 · Cited by 24
“Hairpin 1, designed to target 5′-WTACGTW-3′ (34, 35), downregulates VEGF expression in cell culture and suppresses tumor growth in vivo (35, 36).”
BackgroundModulation of nuclear receptor function: Targeting the protein-DNA interface
Filho, H. V. R., Tambones, I., Dias, M. M. G., Videira, N. B., Bruder, M., Amato, A. A., & Figueira, A. C. M. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.01.023 · Cited by 25
Malinee, M., Kumar, A., Hidaka, T., Horie, M., Hasegawa, K., Pandian, G. N., & Sugiyama, H. (2019) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2019.115248 · Cited by 23
Expanding the Repertoire of Natural Product-Inspired Ring Pairs for Molecular Recognition of DNA
Muzikar, K. A., Meier, J. L., Gubler, D. A., Raskatov, J. A., & Dervan, P. B. (2011) · Organic Letters · doi:10.1021/ol202285y · Cited by 23
Self-citationTsai, S. M., Farkas, M. E., Chou, C. J., Gottesfeld, J. M., & Dervan, P. B. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl1025 · Cited by 23
“They have also been shown to permeate living cells, localize to the nuclei (2,3), and regulate gene expression (4,5).”
BackgroundSelf-citationProgrammable oligomers targeting 5′-GGGG-3′ in the minor groove of DNA and NF-κB binding inhibition
Chenoweth, D. M., Poposki, J. A., Marques, M. A., & Dervan, P. B. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.10.051 · Cited by 22
Self-citationMysore, V. S., Szablowski, J. O., Dervan, P. B., & Frost, P. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-15-0361 · Cited by 24
“Hypoxia induces the expression of about ~100–200 genes mostly related to metabolism, angiogenesis, and apoptosis (37, 38), and in this study, we found that a sequence-specific DNA-binding oligomer (HIF-PA) that is capable of binding to the HRE and inhibiting HIF-mediated gene transcription (19, 39) can overcome MM res…”
Self-citationHo, D., Dose, C., Albrecht, C. H., Severin, P. M. D., Falter, K., Dervan, P. B., & Gaub, H. E. (2009) · Biophysical Journal · doi:10.1016/j.bpj.2009.02.059 · Cited by 21
Self-citationAngiogenic factors: role in esophageal cancer, a brief review
Ladeira, K., Macedo, F., Longatto‐Filho, A., & Martins, S. F. F. (2017) · Esophagus · doi:10.1007/s10388-017-0597-1 · Cited by 20
“Expression of HIF-1α is associated with that of VEGF-C in ESCC and both of these two factors predict patient’s survival [33].”
Wrenchnolol Derivative Optimized for Gene Activation in Cells
Jung, D., Shimogawa, H., Kwon, Y., Mao, Q., Sato, S., Kamisuki, S., Kigoshi, H., & Uesugi, M. (2009) · Journal of the American Chemical Society · doi:10.1021/ja900669k · Cited by 20
Differential Disruption of EWS-FLI1 Binding by DNA-Binding Agents
Chen, C., Wonsey, D. R., Lemieux, M. E., & Kung, A. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069714 · Cited by 18
Eguchi, A., Lee, G. O., Wan, F., Erwin, G. S., & Ansari, A. Z. (2014) · Biochemical Journal · doi:10.1042/bj20140400 · Cited by 20
The hypoxic microenvironment: A determinant of cancer stem cell evolution
Carnero, A., & LLeonart, M. E. (2015) · Inside the Cell · doi:10.1002/icl3.1039 · Cited by 37
Jiang, B., Dong, H., Zhang, Z., Wang, W., Zhang, Y., & Xu, X. (2007) · The Journal of Gene Medicine · doi:10.1002/jgm.1070 · Cited by 19
“Analysis of the VEGF promoter reveals that a single HRE is located at nucleotide positions −947 to −39 (5-TACGTG-3) relative to the common transcription start site [25,26].”
BackgroundVoies moléculaires dans le cancer du rein : de la biologie aux traitements de demain
Edeline, J., Vigneau, C. M., Patard, J., & Rioux-Leclercq, N. C. (2010) · Bulletin du Cancer · doi:10.1684/bdc.2010.1066 · Cited by 22
“Une autre cible potentiellement intéressante dans le cancer du rein est HIF [21].”
BackgroundAn HRE-Binding Py-Im Polyamide Impairs Hypoxic Signaling in Tumors
Szablowski, J. O., Raskatov, J. A., & Dervan, P. B. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0719 · Cited by 20
“Experiments focused on HIF1–DNA binding inhibition demonstrated the ability of 1 to displace the HIF1 complex from DNA in vitro (12), and by reducing HIF1a occupancy at selected HREs in a common tissue culture model of hypoxic response— U251 cells as represented in Fig.”
BackgroundSelf-citationDNA sequence selectivity of hairpin polyamide turn units
Farkas, M. E., Li, B. C., Dose, C., & Dervan, P. B. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.03.072 · Cited by 18
Self-citationSalgado, R. M., White, A. C., Schneider, S. M., & Mermier, C. M. (2014) · Physiology Journal · doi:10.1155/2014/121402 · Cited by 20
Sadeghi, F., Kardar, G. A., Bolouri, M. R., Nasri, F., Sadri, M., & Falak, R. (2020) · Biological Research · doi:10.1186/s40659-020-00293-4 · Cited by 18
12 Arylstibonic acids that inhibit the DNA binding of five B-ZIP dimers
Rishi, V., Oh, W., Heyerdahl, S. L., Zhao, J., Scudiero, D. A., Shoemaker, R. H., & Vinson, C. (2010) · Journal of Structural Biology · doi:10.1016/j.jsb.2010.02.013 · Cited by 19
“Potentially, binding of a B-ZIP protein to DNA can be disrupted in two ways: 1) targeting molecules that bind to the major or minor grooves of DNA causing changes in its topology and steric hindrances such that the transcription factor cannot bind to DNA [10, 11]; or 2) targeting the B-ZIP domain itself.”
BackgroundAltered cytokine profiles in patients with Chuvash polycythemia
Niu, X., Miasnikova, G. Y., Sergueeva, A. I., Polyakova, L. A., Okhotin, D. J., Tuktanov, N. V., Nouraie, M., Ammosova, T., Nekhai, S., & Gordeuk, V. R. (2009) · American Journal of Hematology · doi:10.1002/ajh.21327 · Cited by 16
“HIF translocates to the nucleus and influences the transcription of hypoxia-responsive genes [25–27].”
Backgroundα-Diaminobutyric acid-linked hairpin polyamides
Farkas, M. E., Tsai, S. M., & Dervan, P. B. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.07.019 · Cited by 16
Self-citationA patent review on hypoxia-inducible factor (HIF) modulators (2021–2023)
Liu, J., Gao, Y., & Zhang, X. (2024) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2024.2368739 · Cited by 17
Molecular Recognition of DNA by Py–Im Polyamides: From Discovery to Oncology
Dervan, P. B., Kurmis, A. A., & Finn, P. B. (2018) · Royal Society of Chemistry eBooks · doi:10.1039/9781788012928-00298 · Cited by 17
Self-citationErwin, G. S., Bhimsaria, D., Eguchi, A., & Ansari, A. Z. (2014) · Angewandte Chemie · doi:10.1002/ange.201405497 · Cited by 13
Saha, A., Nandi, P. S., Dasgupta, S., Bhuniya, A., Ganguly, N., Ghosh, T., Guha, I., Banerjee, S., Baral, R., & Bose, A. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00260 · Cited by 13
The Reach of Linear Protein−DNA Dimerizers
Stafford, R., & Dervan, P. B. (2007) · Journal of the American Chemical Society · doi:10.1021/ja075247b · Cited by 12
Self-citationKushal, S., Wang, H., László, C., Szabó, L., & Olenyuk, B. Z. (2010) · Biopolymers · doi:10.1002/bip.21550 · Cited by 12
Self-citationDale, J., Howe, C. P., Toncrova, H., Fritzsch, R., Greetham, G. M., Clark, I. P., Towrie, M., Parker, A. W., McLeish, T. C. B., & Hunt, N. T. (2021) · Physical Chemistry Chemical Physics · doi:10.1039/d1cp02233d · Cited by 12
Lakka, A., Mylonis, I., Bonanou, S., Simos, G., & Tsakalof, A. K. (2010) · Investigational New Drugs · doi:10.1007/s10637-010-9440-4 · Cited by 13
“and synthetic polyamides inhibit HIF-1 DNA binding [11, 12], while chetomin blocks the recruitment of the co-”
BackgroundResearch Article Anticancer and antimicrobial activities of diosmin
Kilit, A. C., Köse, O., Imi, G., & Aydemir, E. (2021) · Genetics and Molecular Research · doi:10.4238/gmr18752 · Cited by 15
Molecular Biology of Kidney Cancer
Kaelin, W. G. (2015) · Springer eBooks · doi:10.1007/978-3-319-17903-2_3 · Cited by 12
Self-citationA Novel PHD2/VHL-mediated Regulation of YAP1 Contributes to VEGF Expression and Angiogenesis
Bora-Singhal, N., Saha, B., Mohankumar, D., Padmanabhan, J., Coppola, D., & Chellappan, S. (2022) · Cancer Research Communications · doi:10.1158/2767-9764.crc-21-0084 · Cited by 11
“es/) identified the binding sites for HIF1α on the VEGF promoter which had been reported previously (49).”
BackgroundSmall organic molecules that modulate gene transcription
Jung, D., Choi, Y., & Uesugi, M. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.03.011 · Cited by 11
Oligomerization Route to Py−Im Polyamide Macrocycles
Chenoweth, D. M., Harki, D. A., & Dervan, P. B. (2009) · Organic Letters · doi:10.1021/ol901311m · Cited by 11
Self-citationRegulation of Transcription by Synthetic DNA‐Bending Agents
Bednarski, D. W., & Firestine, S. M. (2006) · ChemBioChem · doi:10.1002/cbic.200600141 · Cited by 11
Collar, C. J., Lee, M., & Wilson, W. D. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci100191a · Cited by 10
(1994) · Elsevier eBooks · doi:10.1016/c2009-0-02451-9 · Cited by 16
Interactions Between Non-Coding RNAs and HIF-1alpha in the Context of Colorectal Cancer
Gong, L., Zhang, H., Liu, Y., Wang, X., & Xia, R. (2025) · Biomolecules · doi:10.3390/biom15040510 · Cited by 10
“It performs as such by elevating the expression levels of succinate dehydrogenase subunits D, reducing intracellular succinate levels, and suppressing HIF-1 α expression.”
Finn, P. B., Bhimsaria, D., Ali, A., Eguchi, A., Ansari, A. Z., & Dervan, P. B. (2020) · PLoS ONE · doi:10.1371/journal.pone.0243905 · Cited by 9
“An 8-ring hairpin Py-Im polyamide (TpPyPyIm-γ-PyImPyPy-βDp) binds 6 bp of DNA (5’-WTWCGW-3’) [28], whereas a linear polyamide (ImPy-β-ImPyβ-Im-β-Dp) binds 9 bp of purine rich DNA (5’-AAGAAGAAG-3’) [29–32].”
BackgroundSelf-citationSubtle Recognition of 14-Base Pair DNA Sequences via Threading Polyintercalation
Smith, A. R., Ikkanda, B. A., Holman, G. G., & Iverson, B. L. (2012) · Biochemistry · doi:10.1021/bi300317n · Cited by 9
Jain, P., Shah, K., & Rishi, V. (2018) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2018.09.007 · Cited by 10
Approaches to Target the Genome and Its Epigenome in Cancer
Chapman‐Rothe, N., & Brown, R. (2009) · Future Medicinal Chemistry · doi:10.4155/fmc.09.105 · Cited by 11
DNA Minor Groove Binders as Therapeutic Agents
Withers, J. M., Padroni, G., Pauff, S. M., Clark, A. W., Mackay, S. P., & Burley, G. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12561-2 · Cited by 8
Dong, H., Wang, Q., Zhang, Y., Jiang, B., Xu, X., & Zhang, Z. (2009) · Experimental Biology and Medicine · doi:10.3181/0904-rm-130 · Cited by 8
“Research on the VEGF promoter has demonstrated that a single HRE is located at nucleotide positions 947 to - 39 (5-TACGTG-3) related to the common transcription start site (20, 21).”
BackgroundVinson, C. (2005) · Science s STKE · doi:10.1126/stke.2842005pe23 · Cited by 7
“(2) is the demonstration that the polyamide is active in cells.”
BackgroundInfluentialA Cell‐Permeable Synthetic Transcription Factor Mimic
Xiao, X., Yu, P., Lim, H., Sikder, D. S., & Kodadek, T. J. (2007) · Angewandte Chemie · doi:10.1002/ange.200604485 · Cited by 6
Repression of the transcriptional activity of ERRα with sequence-specific DNA-binding polyamides
Chen, C.-Y., Li, Y., Jia, T., He, L., Hare, A. A., Silberstein, A. L., Gallagher, J., Martinez, T. F., Stiles, J. W., Olenyuk, B. Z., et al. (2020) · Medicinal Chemistry Research · doi:10.1007/s00044-019-02493-4 · Cited by 5
Self-citationJensen, C. C., & Warfel, N. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00039-6 · Cited by 5
Combination Strategies Targeting Hypoxia Inducible Factor 1 (HIF-1) for Cancer Therapy
Rapisarda, A., & Melillo, G. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6615-5_1 · Cited by 6
Hypoxia, angiogenesis, and colorectal cancer
Mizukami, Y., & Chung, D. C. (2007) · Current Colorectal Cancer Reports · doi:10.1007/s11888-007-0003-9 · Cited by 5
“Echinomycin and polyamides appear to block binding of HIF-1 to its DNA hypoxia response element [19, 42 ], and chetomin can block the interaction of HIF-1 with CBP/p300 [43].”
Backgroundvon Hippel–Lindau-associated malignancies: Mechanisms and therapeutic opportunities
Kaelin, W. G. (2005) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2005.04.003 · Cited by 8
Self-citationNoncanonical Mechanisms to Regulate Nuclear Receptor Signaling
Sadana, P. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.72 · Cited by 6
Bugalho, M. J., Mendonça, E., Costa, P., Santos, J. R., Silva, E., Catarino, A. L., & Sobrinho, L. G. (2006) · BMC Endocrine Disorders · doi:10.1186/1472-6823-6-6 · Cited by 5
“ceivable that anti-tumor activity may be increased by agents targeting multiple pathways [26-28].”
BackgroundUsing synthetic genome readers/regulators to interrogate chromatin processes: A brief review
Philips, S. J., Danda, A., & Ansari, A. Z. (2024) · Methods · doi:10.1016/j.ymeth.2024.03.001 · Cited by 5
Interference with DNA repair after ionizing radiation by a pyrrole-imidazole polyamide
Diaz-Perez, S. V., Kane, N., Kurmis, A. A., Yang, F., Kummer, N. T., Dervan, P. B., & Nickols, N. G. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196803 · Cited by 5
“We have previously shown that polyamides can modulate a variety of DNA-dependent processes, including transcription factor-DNA binding [12,13], RNA polymerase II elongation [10,14], DNA helicase activity [9], and integration of viral DNA into mammalian cells by integrase [26].”
BackgroundSelf-citationHIF inhibition: Current strategies and clinical challenges
Więch-Walów, A., Bartoszewska, S., Barton, A., Czechowicz, P., Dudzik, J., Wielockx, B., Collawn, J. F., & Bartoszewski, R. (2026) · Redox biology · doi:10.1016/j.redox.2026.104220 · Cited by 3
“Genome-wide expression analyses further revealed coordinated downregulation of multiple hypoxia-inducible genes, supporting targeted disruption of HIF-dependent transcriptional programs [392].”
Seagroves, T. N. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0131-6_16 · Cited by 3
Molecular Biology of Kidney Cancer
Kaelin, W. G. (2011) · Springer eBooks · doi:10.1007/978-3-642-21858-3_3 · Cited by 3
Self-citationŞimşek, E., Aydemir, E. A., İmir, N., Koçak, O., Kuruoğlu, A., & Fışkın, K. (2015) · Neuropeptides · doi:10.1016/j.npep.2015.07.002 · Cited by 3
“(Olenyuk et al., 2004).”
Molecular Basis for the Inhibition of HMGA1 Proteins by Distamycin A
Smith, A. E., & Buchmueller, K. L. (2011) · Biochemistry · doi:10.1021/bi200822c · Cited by 3
Novel Therapeutic Targets in Rheumatoid Arthritis
Sakthiswary, R. (2018) · Medicine & health · doi:10.17576/mh.2018.1301.03 · Cited by 4
Chemical Control of Genes: Synthetic Genome Readers and Gene Regulators
Ansari, A. Z., Mohammed, A., Achari, A., Danda, A., Philips, S. J., Deane, C. D., & Kandikonda, S. (2025) · Chemical Reviews · doi:10.1021/acs.chemrev.5c00112 · Cited by 2
Therapeutic Strategies that Target the HIF System
Cook, K. M., & Schofield, C. J. (2008) · Springer eBooks · doi:10.1007/978-0-387-71518-6_32 · Cited by 2
Heinrich, B., & Vázquez, O. (2020) · Organic Letters · doi:10.1021/acs.orglett.9b04288 · Cited by 2
Şimşek, E., Koçak, O., Yıldırım, K., Kuruoğlu, A., Taşkın, N. D., Bozkurt, S., İmir, N., Ataş, C., Akçit, E. T., Çoban, M., et al. (2023) · Revista Brasileira de Farmacognosia · doi:10.1007/s43450-023-00365-y · Cited by 2
“The forward primer for VEGF was 5'-AGG CCA GCA CAT AGG AGA GA-3' and the reverse primer 5'-TTT CCC TTT CCT CGA ACT GA3' (Olenyuk et al.”
MethodOxygen-responsive p53 tetramer-octamer switch controls cell fatePreprint
Taxak, S., & Pati, U. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/841668 · Cited by 2
CRISPR/Cas9-Editing-Based Modeling of Tumor Hypoxia
Masarkar, N., Ray, S. K., Raghuwanshi, P., Yadav, A. K., & Mukherjee, S. (2023) · Springer eBooks · doi:10.1007/978-981-99-0313-9_13 · Cited by 1
Introduction: Sequence-Specific DNA Binding Pyrrole–Imidazole Polyamides and Their Applications
Kawamoto, Y. (2019) · Springer theses · doi:10.1007/978-981-13-6912-4_1 · Cited by 1
Hypoxic Response and Associated Diseases
Flashman, E., Loenarz, C., & Schofield, C. J. (2008) · Wiley eBooks · doi:10.1002/9780470048672.wecb232 · Cited by 1
HIF‐1 Inhibitors for Cancer Therapy
Rapisarda, A., & Melillo, G. (2010) · Wiley eBooks · doi:10.1002/9780470669891.ch17 · Cited by 1
Transcription‐Based Therapeutics
Wands, A. M., & Mapp, A. K. (2008) · Wiley eBooks · doi:10.1002/9780470048672.wecb607 · Cited by 1
VEGF: Biologic Aspects and Clinical Approaches
Rathmell, W. K., & Rini, B. I. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-332-5_6 · Cited by 1
Oxygen-dependent Regulation of Transcription by the Hypoxia-inducible Factor-1
Ruas, J. L. (2005) · Figshare · Cited by 1
Arndt, H., & Schoof, S. (2007) · ChemBioChem · doi:10.1002/cbic.200700156 · Cited by 2
Organic Chemistry at the Interface to Biology
Clausen, R. P. (2006) · ChemBioChem · doi:10.1002/cbic.200600068 · Cited by 1
Metadata
- Authors
- Olenyuk, B. Z., Zhang, G.-J., Klco, J. M., Nickols, N. G., Kaelin, W. G., & Dervan, P. B.
- Affiliations
- California Institute of Technology (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2004-11-19
- Volume
- 101
- Issue
- 48
- Pages
- 16768-16773
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC534742
- OpenAlex
- W2000975094
- Cited by
- 219
- References
- 48
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 3 · 2023: 7 · 2022: 4 · 2021: 6 · 2020: 10 · 2019: 8 · 2018: 10 · 2017: 5 · 2016: 8 · 2015: 6 · 2014: 9 · 2013: 7 · 2012: 18
- FWCI
- 5.68
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- CaltechAUTHORS (California Institute of Technology) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Physical Sciences › Chemistry › Organic Chemistry › Heterocyclic Compound Synthesis and Bioactivity
- Keywords
- vascular endothelial growth factor, hypoxia response element, hypoxia-inducible factor, polyamide, tumor angiogenesis, hypoxia-inducible gene expression, VEGF mRNA, HeLa cells, gene expression profiling
- MeSH terms
- Hypoxia, Base Sequence, HeLa Cells, Humans, Promoter Regions, Genetic, RNA, Messenger, DNA Primers, Microscopy, Confocal, Reverse Transcriptase Polymerase Chain Reaction, Electrophoretic Mobility Shift Assay, Vascular Endothelial Growth Factor A
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.